Literature DB >> 12645080

Ceramide in rafts (detergent-insoluble fraction) mediates cell death in neurotumor cell lines.

John Kilkus1, Rajendra Goswami, Fernando D Testai, Glyn Dawson.   

Abstract

Detergent-resistant lipid microdomains (Rafts) were isolated from human oligodendroglioma (HOG), human neuroblastoma (LA-N-5), and immortalized dorsal root ganglion (F-11) cell lines by sucrose-density gradient ultracentrifugation and shown to be enriched in cholesterol, sphingomyelin, and ceramide. [(3)H]palmitate labeling allowed the Raft fraction to be easily identified as a sharp peak of (3)H radioactivity in the 5-30% sucrose interphase. Treatment of [(3)H]palmitate-labeled cells with staurosporine (to activate caspase 8 and induce apoptosis) or exogenous sphingomyelinase specifically increased the [(3)H]ceramide content of the Raft fraction. Depletion of cholesterol with beta-methylcyclodextran decreased Raft formation and partially blocked staurosporine-induced apoptosis. Similarly, treatment of cells with Fumonisin B1 to inhibit de novo sphingolipid synthesis by 50% reduced the labeling of the Raft fraction and partially blocked staurosporine-induced apoptosis. Staurosporine treatment activated neutral sphingomyelinase but had no effect on acid sphingomyelinase activity or on other lysosomal hydrolases, such as alpha-L-fucosidase. Most of the neutral sphingomyelinase activity is in the Raft fraction, suggesting that the conversion of sphingomyelin to ceramide in Rafts is an important event in neural cell apoptosis. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12645080     DOI: 10.1002/jnr.10549

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  23 in total

Review 1.  Membrane progesterone receptors: evidence for neuroprotective, neurosteroid signaling and neuroendocrine functions in neuronal cells.

Authors:  Peter Thomas; Yefei Pang
Journal:  Neuroendocrinology       Date:  2012-09-14       Impact factor: 4.914

Review 2.  Role of ganglioside metabolism in the pathogenesis of Alzheimer's disease--a review.

Authors:  Toshio Ariga; Michael P McDonald; Robert K Yu
Journal:  J Lipid Res       Date:  2008-03-11       Impact factor: 5.922

3.  Neutral sphingomyelinase 2 deficiency increases hyaluronan synthesis by up-regulation of Hyaluronan synthase 2 through decreased ceramide production and activation of Akt.

Authors:  Jingdong Qin; Evgeny Berdyshev; Christophe Poirer; Nancy B Schwartz; Glyn Dawson
Journal:  J Biol Chem       Date:  2012-03-01       Impact factor: 5.157

Review 4.  Sphingolipids and lipid rafts: Novel concepts and methods of analysis.

Authors:  Erhard Bieberich
Journal:  Chem Phys Lipids       Date:  2018-09-05       Impact factor: 3.329

5.  Multiple sphingolipid abnormalities following cerebral microendothelial hypoxia.

Authors:  Fernando D Testai; John P Kilkus; Evgeny Berdyshev; Irina Gorshkova; Viswanathan Natarajan; Glyn Dawson
Journal:  J Neurochem       Date:  2014-08-14       Impact factor: 5.372

Review 6.  Secondary alterations of sphingolipid metabolism in lysosomal storage diseases.

Authors:  Alessandro Prinetti; Simona Prioni; Elena Chiricozzi; Edward H Schuchman; Vanna Chigorno; Sandro Sonnino
Journal:  Neurochem Res       Date:  2011-01-05       Impact factor: 3.996

Review 7.  Cancer treatment strategies targeting sphingolipid metabolism.

Authors:  Babak Oskouian; Julie D Saba
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

8.  Ceramide signaling in cancer and stem cells.

Authors:  Erhard Bieberich
Journal:  Future Lipidol       Date:  2008-06

9.  A novel role of the Batten disease gene CLN3: association with BMP synthesis.

Authors:  Judith A Hobert; Glyn Dawson
Journal:  Biochem Biophys Res Commun       Date:  2007-04-19       Impact factor: 3.575

10.  Evidence for coordination of lysosomal (ASMase) and plasma membrane (NSMase2) forms of sphingomyelinase from mutant mice.

Authors:  Jingdong Qin; Glyn Dawson
Journal:  FEBS Lett       Date:  2012-10-06       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.